+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission



Cranial irradiation for preventing brain metastases of small cell lung cancer in patients in complete remission



Cochrane Database of Systematic Reviews: Cd002805-Cd002805



Prophylactic cranial irradiation halves the rate of brain metastases in patients with small cell lung cancer. Individual randomized trials conducted on patients in complete remission were unable to clarify whether this treatment improves survival. This study aims to test whether prophylactic cranial irradiation prolongs survival of patients with small cell lung cancer in complete remission. Published and unpublished trials were eligible. Electronic databases, reference lists of trial publications, review articles and relevant books were used to identify potentially eligible trials. The search was also guided by discussions with investigators and experts, and the examination of meeting proceedings and of the Physician Data Query clinical trial registry. Randomized trials comparing prophylactic cranial irradiation with no prophylactic cranial irradiation in patients with small cell lung cancer in complete remission. Meta-analysis based on updated individual data. The main endpoint was survival. The relative risk of death in the treatment group compared to the control group was 0.84 (95% confidence interval=0.73 to 0.97, P=0.01), corresponding to a 5.4 percent increase in the 3-year survival rate (from 15.3 percent in the control group to 20.7 percent in the treatment group). Prophylactic cranial irradiation also increased disease-free survival (relative risk=0.75, 95% confidence interval=0.65 to 0.86, P<0.001) and decreased the risk of brain metastases (relative risk=0.46, 95% confidence interval=0.38 to 0.57, P<0.001). Increasing doses of irradiation decreased the risk of brain metastases when four groups (8 Gy, 24-25 Gy, 30 Gy, 36-40 Gy) were analyzed [trend test, P=0.02], but the effect on survival did not differ significantly according to the dose. We found a trend (P=0.01) for a decrease in the brain metastasis risk in favour of earlier administration of cranial irradiation after the initiation of induction treatment. Prophylactic cranial irradiation significantly improves survival and disease-free survival for patients with small cell lung cancer in complete remission. Further clinical trials are needed to confirm the potential greater benefit on brain metastasis rate suggested when cranial irradiation is given earlier or at higher doses.

(PDF emailed within 0-6 h: $19.90)

Accession: 045667751

Download citation: RISBibTeXText

PMID: 11034766

DOI: 10.1002/14651858.cd002805


Related references

Prevalence of brain metastases immediately before prophylactic cranial irradiation in limited disease small cell lung cancer patients with complete remission to chemoradiotherapy: a single institution experience. Journal of Thoracic Oncology 3(6): 652-655, 2008

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small cell lung cancer. Cochrane Database of Systematic Reviews 2005(2): Cd005221, 2005

Prophylactic cranial irradiation for preventing brain metastases in patients undergoing radical treatment for non-small-cell lung cancer: a Cochrane Review. International Journal of Radiation Oncology, Biology, Physics 63(3): 690-694, 2005

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. New England Journal of Medicine 341(7): 476-484, Aug 12, 1999

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Journal of the National Cancer Institute 87(3): 183-190, 1995

Prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Prophylactic Cranial Irradiation Overview Collaborative Group. New England Journal of Medicine 341(7): 476-484, 1999

Controlled clinical trial of prophylactic cranial irradiation for patients with small-cell lung cancer in complete remission. Lung Cancer 21(3): 193-201, 1998

Brain Metastases in Patients with Limited Small Cell Lung Cancer Achieving Complete Remission. Chest Journal 96(6): 1332-1335, 1989

Cranial irradiation in patients with EGFR-mutant non-small cell lung cancer brain metastases. Translational Lung Cancer Research 5(1): 134-137, 2016

Brain metastases in patients with limited small cell lung cancer achieving complete remission. Correlation with TNM staging. Chest 96(6): 1332-1335, 1989

Systemic chemotherapy after cranial irradiation in patients with brain metastases from non-small cell lung cancer: a retrospective study. Lung Cancer 63(3): 405-409, 2008

Outcome in patients with small cell lung cancer re-irradiated for brain metastases after prior prophylactic cranial irradiation. Lung Cancer 101: 76-81, 2016

Selecting patients with extensive-stage small cell lung cancer for prophylactic cranial irradiation by predicting brain metastases. Journal of Thoracic Oncology 6(4): 808-812, 2011

Prophylactic Cranial Irradiation for Patients With Locally Advanced Non-Small-Cell Lung Cancer at High Risk for Brain Metastases. Clinical Lung Cancer 16(4): 292-297, 2016

Prophylactic cranial irradiation in limited disease small-cell lung cancer in complete remission: a retrospective analysis. Respiratory Medicine 95(3): 235-236, 2001